ArticleCellular oncology (Dordrecht, Netherlands)2025

Cancer-associated fibroblasts and metabolic reprogramming predict pathologic response to neoadjuvant PD-1 blockade in resected non-small cell lung cancer.

Jiaqi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.